Molecular Profiles and Lifestyle Factors in Breast Cancer Prognosis

乳腺癌预后中的分子谱和生活方式因素

• 批准号: 7795198
• 负责人: BETTE J CAAN
• 金额: $ 76.56万
• 依托单位: KAISER FOUNDATION RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-04-01 至 2014-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7795198
• 关键词: Address; African American; Age; Archives; Area; Behavior; Behavioral; Biological; Biological Assay; Body Size; Body Weight Changes; Breast Cancer Risk Factor; Breast Feeding; California; Cancer Patient; Cancer Prognosis; Cancer Survivor; Cancer Survivorship; Caring; Cessation of life; Characteristics; Classification; Clinical; Clinical Data; Cohort Studies; Cost Savings; Cytokeratin; Data; Death Certificates; Diagnosis; Diet; Dietary Practices; Disease; Disease-Free Survival; Eligibility Determination; Epidemiology; Epidermal Growth Factor Receptor; Ethnic Origin; Etiology; Fatty acid glycerol esters; Freezing; Funding; Gene Expression; Goals; Heterogeneity; Hormone Receptor; Hormones; Human; Knowledge; Laboratories; Life; Life Style; Malignant Neoplasms; Medical; Medical Records; Menopausal Status; Methods; Molecular; Molecular Classification of Tumors; Molecular Profiling; Obesity; Outcome; Paraffin Embedding; Participant; Pathway interactions; Patient Self-Report; Physical activity; Population Heterogeneity; Positioning Attribute; Prevalence; Prognostic Factor; Prospective Studies; Public Health; Questionnaires; Race; Recruitment Activity; Recurrence; Reporting; Request for Proposals; Research; Research Personnel; Resources; Risk Factors; Sampling; Selection for Treatments; Self-Administered; Specimen; Staging; Suggestion; Surrogate Markers; Technology; Time; Tissues; Tumor Tissue; Variant; Weight; Weight Gain; Woman; Work; base; breast cancer diagnosis; cancer care; cancer epidemiology; cell type; cohort; cost; energy balance; epidemiology study; follow-up; improved; infancy; innovation; lifestyle factors; malignant breast neoplasm; molecular marker; new technology; older women; outcome forecast; parity; population based; programs; public health relevance; therapy development; tumor

DESCRIPTION (provided by applicant): In recent years, new technologies have allowed us to better characterize the heterogeneity of breast cancer and to identify a number of biological subtypes based on their molecular profiles. Consequently, molecular classification of tumors is increasingly being used to guide treatment selection and new treatment development, in evaluating prognosis, and in studies of etiology. One molecular classification, the "intrinsic subtype", which distinguishes among breast cancers based on either their cell type of origin (luminal A/B or basal) or whether the tumor is HER2-positive, has been used to identify biologically and clinically distinct subtypes of breast cancer. The primary goal of this proposal is to examine the effects of intrinsic subtypes and their relationship to breast cancer risk factors and short and long-term prognosis in two ongoing cohort studies of breast cancer survivors (N=4177) being conducted within the Kaiser Permanente of Northern California (KPNC) Medical Care program. The first study, the Life After Cancer Epidemiology (LACE) cohort, a population-based cohort of 2,288 women diagnosed with Stage I>1 cm, II, or IIIa breast cancer, was established in 2000- 2002 to examine behavioral factors and breast cancer prognosis. These data will be combined with 1890 additional cases of similar stage from the Pathways cohort, a study of short term breast cancer survivors which began in January 2006. Given the inconsistency observed to date in findings between energy related factors and prognosis and the suggestion that effects may vary by tumor characteristics such as hormone receptor status, a secondary goal of this proposal is to examine whether specific behaviors related to energy balance may be related to prognosis among breast cancer patients in general or primarily among women with certain intrinsic subtypes Since most studies have only reported on effects of energy related factors on short term prognosis, another secondary goal of this proposal is to continue to follow women in the LACE cohort up until 15 year post-diagnosis and to examine the relationship of energy related lifestyle factors with long-term prognosis. Data on weight, weight change, physical activity and diet were collected at multiple time points post diagnosis. Women are followed annually for recurrence and death by self report and verified by medical record and death certificates. During the proposed new funding period, archived tumor blocks will be retrieved and, using immunohistochemical assays (IHC), breast cancers will be classified into intrinsic subtypes. This study will achieve tremendous cost savings by examining the proposed questions within two existing cohort of cancer survivors for whom post diagnosis data on behavior are already available and by retrieving tumor specimens within a cohort where close to 90% the women belong to the KPNC, an HMO, where tumor specimens are readily accessible. Our proposal addresses a range of issues that are emerging priority areas in cancer survivorship research which will have both clinical and public health impact. PUBLIC HEALTH RELEVANCE: A limited number of studies with relatively small samples or short-term follow-up have classified tumors into intrinsic subtypes and examined their association with clinical tumor characteristics or survival. An even smaller number have looked at breast cancer risk factors. The combined LACE and Pathways cohorts, as proposed in this study constitutes one of the largest resources on breast cancer survivors with already collected clinical data from medical charts and lifestyle and other factors from self- administered questionnaires. The addition of the proposed intrinsic subtype (IHC) molecular markers to this resource provides an innovative and cost-efficient method for classifying breast cancer subtypes (IHC assays can be done on archived tumor tissue) that will improve our understanding of variation in prognosis, and also allows for the unique combination of molecular and behavioral information to help better understand which women are most likely to benefit from changes in lifestyle after a breast cancer diagnosis, information of both clinical and public health significance. This population-based cohort is uniquely positioned to address several important gaps in our knowledge about cancer survivorship.

描述（由申请人提供）：近年来，新技术使我们能够更好地表征乳腺癌的异质性，并根据其分子谱鉴定许多生物亚型。因此，肿瘤的分子分类越来越多地用于指导治疗选择和新治疗开发、评估预后和病因学研究。一种分子分类，即“内在亚型”，根据细胞来源类型（管腔 A/B 或基底细胞）或肿瘤是否 HER2 阳性来区分乳腺癌，已被用来识别生物学和临床上不同的亚型乳腺癌。该提案的主要目标是在 Kaiser Permanente 进行的两项正在进行的乳腺癌幸存者 (N=4177) 队列研究中，检查内在亚型的影响及其与乳腺癌危险因素以及短期和长期预后的关系。北加州 (KPNC) 医疗保健计划。第一项研究是癌症流行病学 (LACE) 队列，这是一个以人群为基础的队列，由 2,288 名被诊断患有 I>1 cm、II 或 IIIa 期乳腺癌的女性组成，于 2000 年至 2002 年建立，旨在检查行为因素和乳腺癌预后。这些数据将与来自 Pathways 队列的 1890 个类似阶段的其他病例相结合，这是一项于 2006 年 1 月开始的针对短期乳腺癌幸存者的研究。鉴于迄今为止观察到的能量相关因素与预后之间的结果不一致，以及影响可能因肿瘤特征（例如激素受体状态）而异，该提案的第二个目标是检查与能量平衡相关的特定行为是否可能与一般乳腺癌患者或主要是具有某些内在亚型的女性的预后相关，因为大多数研究都仅有的报告了能量相关因素对短期预后的影响，该提案的另一个次要目标是继续跟踪 LACE 队列中的女性直至诊断后 15 年，并检查能量相关生活方式因素与长期预后的关系。在诊断后的多个时间点收集有关体重、体重变化、体力活动和饮食的数据。每年通过自我报告跟踪妇女的复发和死亡情况，并通过医疗记录和死亡证明进行核实。在拟议的新资助期内，将检索存档的肿瘤块，并使用免疫组织化学测定（IHC）将乳腺癌分为内在亚型。这项研究将通过检查现有的两个癌症幸存者队列中提出的问题来实现巨大的成本节省，这些幸存者的诊断后行为数据已经可用，并且通过检索其中近 90% 的女性属于 KPNC 的队列中的肿瘤标本， HMO，可以轻松获取肿瘤样本。我们的提案解决了癌症生存研究中新兴优先领域的一系列问题，这些问题将对临床和公共卫生产生影响。公共卫生相关性：数量相对较小或短期随访的有限研究已将肿瘤分为内在亚型，并检查了它们与临床肿瘤特征或生存的关系。更少的人研究了乳腺癌的危险因素。本研究中提出的 LACE 和 Pathways 队列组合构成了乳腺癌幸存者的最大资源之一，这些资源已经从医疗图表和生活方式以及自填问卷中的其他因素中收集了临床数据。将拟议的内在亚型 (IHC) 分子标记添加到该资源中，为乳腺癌亚型分类提供了一种创新且经济高效的方法（IHC 检测可以在存档的肿瘤组织上进行），这将提高我们对预后变化的理解，以及还允许分子和行为信息的独特组合，以帮助更好地了解哪些女性最有可能从乳腺癌诊断后生活方式的改变中受益，这些信息具有临床和公共卫生意义。这个基于人群的队列具有独特的优势，可以解决我们在癌症生存方面的知识中的几个重要差距。